Should I buy Paycom (PAYC) stock or is it too late?

Paycom · Industrials · price $237
Logo PaycomSee the full Paycom (PAYC) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Keybanc65% of its targets hit on this sector (207 calls tested). It aims for $270 (+14 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).

The 4 reliable analysts $203-15 %
The 7 other firms $225-5.1 %
How to read it: the 4 reliable firms are not filtered by optimism — 1 aim above the price, 3 below, hence their $203 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Paycom

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Barclays100 %+92.4 %9$210 -11%
Stifel67 %+52.6 %9$200 -16%
Jefferies80 %+20.3 %5$130 -45%
Oppenheimer50 %+17.5 %12$400 +69%
Keybanc52 %+9.4 %21$270 +14%
Citigroup38 %-7.8 %8$194 -18%
Piper Sandler17 %-19.2 %18$399 +68%
Needham40 %+10.2 %15
In short — Should you invest in Paycom? Is it too late, still worth it? Analysts are split (45% buy, median target $210, i.e. -11%). But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • Few solid positives from analysts right now: of 11 ratings, only 5 buys, and the median price target ($210) is -11% below the price ($237). Caution prevails.

⚠️ Reasons to hesitate

  • Even the most reliable firm on PAYC, Barclays (100% hit rate, 9 scored calls), only targets $210 (call made on August 6, 2026, maturing on August 6, 2027) (-11%) in its most recent call, and $225 (call made on October 21, 2025, maturing on October 21, 2026) (-5%) in the one coming due soonest. The stock may already have run past its target.
  • The consensus is not unanimous: of 11 ratings, 6 are neutral.
  • Limited upside: the median target is only -11% from the current price.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on PAYC

Median target $210 (-11%) · 11 ratings · Hold consensus

Strong Buy00%
Buy545%
Hold655%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Paycom now?

We won't decide for you. The facts: 45% of analysts rate it a buy, median target $210 (-11%), and Barclays (most reliable on PAYC, 100%) targets $210. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Paycom?

The stated upside is small: the median target ($210) sits just -11% from the price ($237) (most reliable on PAYC: Barclays, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Paycom still worth investing in?

It depends on the gap between the price ($237) and its estimated value: analysts target $210 on median (-11%), with 45% buys (most reliable on PAYC: Barclays, 100%). Cross-check with their real reliability on PAYC and the cautions above. Information, not advice.

What's the main risk in buying PAYC?

Even the most reliable firm on PAYC, Barclays (100% hit rate, 9 scored calls), only targets $210 (call made on August 6, 2026, maturing on August 6, 2027) (-11%) in its most recent call, and $225 (call made on October 21, 2025, maturing on October 21, 2026) (-5%) in the one coming due soonest. The stock may already have run past its target.

→ Go deeper: the full Paycom profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)